Shares of Cabot Corporation (NYSE:CBT – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $70.01 and traded as high as $75.40. Cabot shares last traded at $74.4630, with a volume of 354,641 shares.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on CBT shares. UBS Group raised their price target on shares of Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. Mizuho set a $75.00 price objective on shares of Cabot and gave the stock a “neutral” rating in a report on Wednesday, February 4th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $85.00 price objective on shares of Cabot in a report on Wednesday, February 4th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $73.75.
Read Our Latest Stock Analysis on CBT
Cabot Price Performance
Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings data on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.13. The company had revenue of $849.00 million during the quarter, compared to the consensus estimate of $889.11 million. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The firm’s revenue was down 11.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.76 EPS. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, sell-side analysts predict that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Cabot
Hedge funds have recently modified their holdings of the company. Ashton Thomas Private Wealth LLC boosted its stake in shares of Cabot by 343.9% during the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 65,561 shares of the specialty chemicals company’s stock valued at $4,986,000 after purchasing an additional 50,792 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Cabot by 5.0% during the third quarter. Dimensional Fund Advisors LP now owns 1,556,762 shares of the specialty chemicals company’s stock worth $118,392,000 after acquiring an additional 73,734 shares in the last quarter. Elo Mutual Pension Insurance Co bought a new position in Cabot during the 3rd quarter valued at approximately $1,040,000. Paradiem LLC increased its position in Cabot by 65.5% during the 3rd quarter. Paradiem LLC now owns 149,097 shares of the specialty chemicals company’s stock valued at $11,339,000 after buying an additional 59,030 shares in the last quarter. Finally, Royce & Associates LP increased its position in Cabot by 37.5% during the 3rd quarter. Royce & Associates LP now owns 106,980 shares of the specialty chemicals company’s stock valued at $8,136,000 after buying an additional 29,202 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
See Also
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
